Whitehawk Therapeutics, Inc.
WHWK- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001422142
No open-market purchases or sales by Whitehawk Therapeutics, Inc. insiders were filed in the last 90 days; 77 institutions reported holding it in 13F filings for Q2 2026, worth $198.0M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Whitehawk Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- +13 vs. Q3 2021
- Shares held
- 12.2M
- +1.09M (+9.8%) vs. Q3 2021
- Total value
- $294.2M
- −$29.9M (−9.2%) vs. Q3 2021
- New holders
- 19
- 11 more added
- Sold out
- 6
- 5 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting WHWK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 77 | $198.0M |
| Q1 2026 | 62 | $118.2M |
| Q4 2025 | 48 | $79.2M |
| Q3 2025 | 41 | $54.3M |
| Q2 2025 | 39 | $54.6M |
| Q1 2025 | 50 | $56.2M |
| Q4 2024 | 53 | $47.2M |
| Q3 2024 | 52 | $24.7M |
| Q2 2024 | 65 | $16.7M |
| Q1 2024 | 60 | $30.9M |
| Q4 2023 | 65 | $25.8M |
| Q3 2023 | 73 | $75.3M |
| Q2 2023 | 67 | $100.8M |
| Q1 2023 | 70 | $106.6M |
| Q4 2022 | 76 | $192.2M |
| Q3 2022 | 68 | $212.1M |
| Q2 2022 | 68 | $159.3M |
| Q1 2022 | 55 | $213.8M |
| Q4 2021 | 46 | $294.2M |
| Q3 2021 | 33 | $324.1M |
| Q2 2021 | 43 | $51.0M |
| Q1 2021 | 42 | $34.3M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Whitehawk Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Avoro Capital Advisors LLC | 1,829,402 | $44.2M | 0.75% | 00.0% | Unchanged |
| Acuta Capital Partners, LLC | 1,529,402 | $36.9M | 15.53% | 00.0% | Unchanged |
| VR Adviser, LLC | 1,529,402 | $36.9M | 5.05% | 00.0% | Unchanged |
| Vivo Capital, LLC | 1,303,390 | $31.5M | 1.90% | −123,823−8.7% | Reduced |
| BVF Inc | 899,392 | $21.7M | 0.79% | −247,660−21.6% | Reduced |
| RTW Investments, LP | 764,701 | $18.5M | 0.27% | 00.0% | Unchanged |
| Vanguard Group Inc | 761,473 | $18.4M | 0.00% | +643,196+543.8% | Added |
| Rock Springs Capital Management LP | 538,835 | $13.0M | 0.30% | −225,866−29.5% | Reduced |
| Price T Rowe Associates Inc | 508,892 | $12.3M | 0.00% | +43,293+9.3% | Added |
| Satter Management Co., L.P. | 374,785 | $9.05M | 9.21% | 00.0% | Unchanged |
| State Street Corp | 311,400 | $7.52M | 0.00% | +311,400 | New |
| BlackRock Inc. | 309,554 | $7.47M | 0.00% | +293,304+1,804.9% | Added |
| Citadel Advisors LLC | 230,529 | $5.57M | 0.01% | +131,336+132.4% | Added |
| Ghost Tree Capital, LLC | 200,000 | $4.83M | 1.85% | +200,000 | New |
| Geode Capital Management, LLC | 197,073 | $4.76M | 0.00% | +168,970+601.3% | Added |
| Ikarian Capital, LLC | 196,408 | $4.74M | 1.36% | +185,000+1,621.7% | Added |
| Renaissance Technologies LLC | 128,522 | $3.10M | 0.00% | −37,133−22.4% | Reduced |
| OrbiMed Advisors LLC | 127,600 | $3.08M | 0.04% | −218,662−63.1% | Reduced |
| HighVista Strategies LLC | 40,549 | $979.0K | 0.78% | +40,549 | New |
| Northern Trust Corp | 36,808 | $889.0K | 0.00% | +36,808 | New |
| Citigroup Inc | 36,166 | $873.0K | 0.00% | +35,518+5,481.2% | Added |
| Bank of America Corp | 35,903 | $867.0K | 0.00% | +35,903 | New |
| TD Asset Management Inc | 34,783 | $840.0K | 0.00% | +34,783 | New |
| Marshall Wace, LLP | 29,173 | $704.0K | 0.00% | +29,173 | New |
| Rafferty Asset Management, LLC | 27,967 | $675.0K | 0.00% | +27,967 | New |
| ABG Innovation Capital Partners III GP Ltd | 26,666 | $644.0K | 37.25% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 24,952 | $603.0K | 0.02% | +24,952 | New |
| Alps Advisors Inc | 24,174 | $584.0K | 0.01% | +24,174 | New |
| UBS Group AG | 24,094 | $581.0K | 0.00% | +23,854+9,939.2% | Added |
| Susquehanna International Group, LLP | 21,957 | $530.0K | 0.00% | +21,957 | New |
| 683 Capital Management, LLC | 18,025 | $435.0K | 0.02% | +18,025 | New |
| Schonfeld Strategic Advisors LLC | 15,800 | $381.0K | 0.00% | +15,800 | New |
| Bank of New York Mellon Corp | 11,306 | $273.0K | 0.00% | +11,306 | New |
| Cubist Systematic Strategies, LLC | 10,975 | $265.0K | 0.00% | +10,975 | New |
| Ascent Wealth Partners, LLC | 10,000 | $241.0K | 0.04% | +10,000 | New |
| Parallel Advisors, LLC | 6,408 | $155.0K | 0.01% | 00.0% | Unchanged |
| US Bancorp | 3,333 | $80.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 2,691 | $65.0K | 0.00% | +2,600+2,857.1% | Added |
| Wells Fargo & Company | 794 | $19.0K | 0.00% | +714+892.5% | Added |
| Advisor Group Holdings, Inc. | 259 | $6.00K | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 232 | $5.68K | 0.00% | +232 | New |
| Tower Research Capital LLC (TRC) | 170 | $4.00K | 0.00% | +130+325.0% | Added |
| Simplex Trading, LLC | 100 | $2.00K | 0.00% | +100 | New |
| Investmark Advisory Group LLC | 100 | $2.00K | 0.00% | +100 | New |
| Truepoint, Inc. | 10,219 | $0 | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 15 | $0 | 0.00% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −347,668−100.0% | Sold out |
| Opaleye Management Inc. | 0 | $0 | 0.00% | −45,020−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −28,343−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −20,343−100.0% | Sold out |
| NEXT Financial Group, Inc | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |